tirzepatide perimenopause Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 tirzepatide for perimenopause glp 1

GLP-1 helps keep this in check

These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements

Semaglutide (Wegovy) recently became the first GLP-1 approved by the FDA to treat adults with MASH with moderate-to-advanced fibrosis, based on the phase 3 ESSENCE trial

Mounjaro is administered as a once-weekly subcutaneous injection , with doses ranging from 2.5 mg (starting dose) up to 15 mg for maintenance therapy